🇺🇸 FDA
Pipeline program

Oxymetazoline HCL 1.0% Cream

CMO-MA-MED-0530

Approved small_molecule completed

Quick answer

Oxymetazoline HCL 1.0% Cream for Rosacea is a Approved program (small_molecule) at Aclaris Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Aclaris Therapeutics
Indication
Rosacea
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials